Latest filing: trade of 18 Sept 2024 for BIRZEIT PHARMACEUTICALS. The register gives no publication date.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Aswaq for investment portfolios: trading record in brief
All filings by Aswaq for investment portfolios on record concern Birzeit Pharmaceuticals. In total, 10 filings cover trades dated from 23 July 2019 to 18 September 2024.
Purchases make up the whole of the open-market record (10 purchases). The amount is not disclosed for 10 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2024 to date brings 1 purchase and no sales.
Most recently, on 18 September 2024, the filings show an open-market purchase in Birzeit Pharmaceuticals. These figures are compiled from regulatory filings published by PCMA / Palestine Exchange. They describe what insiders did and are not a recommendation.
Companies and markets linked to Aswaq for investment portfolios
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 341 sharesSharePEXPEX:ac0fbc0dc4ff-1Canonical exit: 17 Dec 2024 (T+90)
- 204 sharesSharePEXPEX:b751a5492619-1Canonical exit: 16 Apr 2022 (T+90)
- 4,000 sharesSharePEXPEX:9a01ba1f19ac-1Canonical exit: 7 Mar 2022 (T+90)
- 1,100 sharesSharePEXPEX:01d672907849-1Canonical exit: 20 Feb 2021 (T+90)
- 6,214 sharesSharePEXPEX:4b726f327c83-1Canonical exit: 21 Oct 2020 (T+90)
- 1,120 sharesSharePEXPEX:f3060e7c95a0-1Canonical exit: 10 Mar 2020 (T+90)
- 6,731 sharesSharePEXPEX:010dd127eace-1Canonical exit: 26 Feb 2020 (T+90)
- 2,000 sharesSharePEXPEX:a5f4fc3e0b9b-1Canonical exit: 24 Feb 2020 (T+90)
- 100 sharesSharePEXPEX:9ef6a3c97724-1Canonical exit: 12 Jan 2020 (T+90)
- 1,200 sharesSharePEXPEX:f79066486645-1Canonical exit: 21 Oct 2019 (T+90)
10 of 10 declarations